Type 2 diabetes mellitus (T2DM) is a chronic metabolic disease that requires lifelong therapy to control blood glucose. The long term use and different mechanism of action antidiabetic have the potential cause side effects and discomfort that affects the quality of life. This study aimed to determine differences in the quality of life of patients with T2DM based on antidiabetic prescribed and complications at the Outpatient of Panembahan Senopati Bantul Yogyakarta Hospital in September 2017. This research is observational with a cross-sectional design. Quality of life data is taking concurrently using the Diabetes Quality of Life Clinical Trial Questionnaire and patient's medical record. This study involved 200 T2DM patients who received antidiabetic at least 3 months before study, aged ≥18 years and agreed to inform concent. Sociodemographic data, antidiabetic prescribed and complications were described descriptively. Differences in the quality of life based on antidiabetic prescribed and complications using the Kruskal Wallis test which was further analyzed using the post hoc by Mann Whitney test. The results showed the majority of patients received oral combination with insulin (48.5%) and dominated by macrovascular complications (19.5%). The average value of patient's quality of life is 65.7. There was difference quality of life based on antidiabetic prescribed in the domain of treatment satisfaction (p=0.000) between oral monotherapy with combination of oral and insulin (p=0.000) and insulin monotherapy with combination of oral and insulin (p=0.002). There were differences in quality of life based on complications in the mental health domain (p=0.003) between macrovascular and microvascular (p=0.011) and between microvascular and without complications (p=0.001).
Diabetes Melitus (DM) tipe 2 merupakan penyakit kronis yang membutuhkan terapi untuk mengontrol glukosa darah. Pengontrolan glukosa darah yang buruk berdampak pada penurunan kualitas hidup dan peningkatan biaya. Tujuan penelitian adalah menganalisis perbedaan outcome klinis yaitu kadar Glukosa Darah Sewaktu (GDS) selama 3 bulan berdasarkan kualitas hidup dan biaya medis langsung. Outcome klinis dikatakan terkontrol apabila GDS <200 mg/dL dan tidak terkontrol apabila GDS ≥200 mg/dL. Rancangan penelitian ini adalah cross sectional dengan jenis observasional. Kriteria inklusi mencakup pasien DM tipe 2 yang memperoleh antidiabetik yang sama minimal 3 bulan di Instalasi Rawat Jalan RSUD Panembahan Senopati Bantul pada September 2017. Kriteria eksklusi meliputi kondisi hamil atau menyusui. Pengambilan data dilakukan melalui pengisian kuesioner, rekam medis dan bagian keuangan. Data demografi dianalisis secara deskriptif sedangkan outcome klinis diolah menggunakan uji Kruskal Wallis. Hasil penelitian menunjukkan sebanyak 129 dari 200 pasien menunjukkan outcome klinis tidak terkontrol (64,5%) dengan rata-rata nilai kualitas hidup yang baik (65,7±7,7) serta mengeluarkan biaya medis langsung sebesar Rp 489.005. Terdapat perbedaan outcome klinis berdasarkan kualitas hidup (p=0,000) pada domain fungsi fisik (p=0,034), kepuasan pribadi (p=0,000), kepuasan pengobatan (p=0,000) dan frekuensi gejala penyakit (p=0,012) serta berdasarkan biaya medis langsung (p=0,012). Pasien dengan outcome klinis terkontrol menunjukkan kualitas hidup yang lebih tinggi dan mengeluarkan biaya lebih rendah.
Type 2 Diabetes mellitus (T2DM) is a chronic disease that requires long-term treatment. There were problems related to antidiabetic medication adherence. Medication adherence directly affects patient’s blood glucose level. The aim of this study was to analyze the association between the medication adherence and glycemic control among T2DM patients. The study was an observational with cross sectional design. Participants were 90 of T2DM outpatient at “X” Buleleng General Hospital in July-September 2020. T2DM patients were included if age ?18 years, received the same antidiabetic for three months before the study, sign informed consent, fill out the questionnare and have fully medical record data. Patient are excluded if having weak general condition, were pregnant or breastfeeding. Data was collected through interview using the Probabilistic Medication Adherence Scale (ProMAS) questionnaire and based on patient’s medical records. Data were analyzed with Kruskall-Wallis test. The results showed that most of patients were male (55.6%), aged 46-65 years (61.1%), had DM for 5-10 years (46.7%), elementary school (37.8%), with comordbidities (50%) and without complications (77.8%). Majority of patients (42.2%) showed moderate-high medication adherence and the majority of patients (66.7%) has uncontrolled blood glucose. Based on statistical tests, there was no association between medication adherence with patient’s glycemic control (p=0.168). In dispite of it, finding showed that the level of medication adherence had an impact on glycemic control. Patients with high medication adherence showed better glycemic control.
Knowledge is important to control blood sugar and prevent complications and subsequently have an impact on the quality of life (QOL) of type 2 diabetes mellitus (T2DM) patients as a response to their health. This study aimed to determine the correlation between level of knowledge and QOL in type 2 DM (T2DM) patients, also its related factors. This cross-sectional study was conducted in a Public Hospitals, Buleleng, Bali on September 2020. Inclusion criteria included T2DM outpatients who ≥aged 18 years, get similar therapy for at least 3 months, filling out the questionnaire completely, able to communicate well, and not in a pregnant/breastfeeding condition. Data were obtained by medical records, questionnaires DKQ-24 (knowledge) and EQ-5D-5L (QOL). Correlation between knowledge and QOL of T2DM patients and its related factors were analyzed using bivariate statistical tests. Finding of 150 respondents demonstrated mostly were ≥60 years old (53.3%), female (50.7%), first educational level (64%), not working (54%), low income (49.3%), >5 years of T2DM duration (44%), no complications (75.3%), taking 4-6 item medicines (66.7%), moderate knowledge level (70.7%) with QOL based on the utility score was 0.892±0.154 and VAS was 59.73±20.07. Statistical tests showed there was a significant correlation between knowledge and QOL based on utility value (p=0.01), but not with VAS value (p=0.165). These was reinforced by age has a significant correlation with knowledge (p=0.042), also employment status and complications condition has a significant correlation with QOL (p<0.05). Patients with a higher level of knowledge have a better QOL, despite different backgrounds.
Kurangnya informasi terkait penggunaan obat menyebabkan terjadinya kesalahan dalam pengobatan. Hal ini dapat disebabkan oleh pengobatan sendiri atau swamedikasi. Salah satu desa yang masyarakatnya menerapkan swamedikasi adalah Desa Bongkasa. Namun, swamedikasi di sana tidak sepenuhnya benar. Tujuan dari program ini adalah untuk meningkatkan pemahaman masyarakat mengenai "Tanya 5 O". Sasaran program ini adalah kelompok Pembinaan Kesejahteraan Keluarga (PKK) dengan metode ceramah, dan pemberian leaflet dan kuesioner untuk mengukur tingkat pengetahuan dan kepuasan responden. Analisis data menggunakan secara statistik dan perhitungan menggunakan Microsoft excel. Hasil menunjukkan pengetahuan responden mengalami peningkatan signifikan dari 54,28% menjadi 81,87% (p=0,000). Kesimpulan dari kegiatan ini adalah terjadi peningkatan pemahaman responden mengenai kegiatan ini, sehingga diharapkan mampu meningkatkan kesadaran perilaku dalam melakukan swamedikasi dengan benar guna mewujudkan penggunaan obat yang tepat, bermutu dan aman.
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.
hi@scite.ai
10624 S. Eastern Ave., Ste. A-614
Henderson, NV 89052, USA
Copyright © 2024 scite LLC. All rights reserved.
Made with 💙 for researchers
Part of the Research Solutions Family.